Barkworth

Barkworth

I think we may have topped out for now. If you are not in a bullish position right now, perhaps it is wise to hold until resistance is broken, or wait for it to retrace to the 50MA. Indicators show that we're a tiny tad extended atm. Take a look at ZYNE, if CBD Pharma is your game. Just my 2 cents. It's free. Trade with caution.

Barkworth

Double bottom in an uptrend: - The double bottom looks like the letter "W". The twice-touched low is considered a support level. - The advance of the first bottom should be a drop of 10% to 20%, then the second bottom should form within 3% to 4% of the previous low, and volume on the ensuing advance should increase. - The double bottom pattern always follows a...

Barkworth Updated 

Not much support on the way down. Congratulations to the bears.

Barkworth Updated 

I got in at $3.66. Been in and out, trying to sell the rallies and buy the dip. It has been an interesting ride with some extreme gains. Needless to say that my position is bullish. So... what's next? My play with ZYNE is aimed at the CBD legislation that is expected at around October this year. ZYNE has many good patents, ready to market, and once CBD as an...

Barkworth Updated 

8 and 26 EMA crossed bullish on the 4hr chart. Daily indicators are hitting the sweet spots. If we can just get her above the 50MA, we may be looking at the start of another bull run. Needs to push just a little higher. Levels on watch!

Barkworth Updated 

As requested, a Gann box for ZYNE. As you can see, it is very compliant with the levels. Of course, the stock can move anywhere at any time, but as soon as you get a sense of short term direction, the lines help identify patterns, resistance and support, fairly early on. I got in at $3.60. Needless to say that I LOVE ZYNE... for now :P

Barkworth Updated 

I took a position this morning, when ACB broke $8.10 bullish. Currently residing right below the trend line and bouncing. I am speculating on a good earnings call to push her through, back on track to the lower $10 range. With today's 4% up, there is at least a margin to get out in case of a catastrophe. But when last earnings disappointed, ACB came with guidance....

Barkworth Updated 

A bullish confirmation could trigger a new bullish trend for Choom. Levels on watch.

Barkworth Updated 

ZYNE was consolidating healthily and with some extreme volatility. Yesterday we got the good news (fast track for ZYN002), and immediately some renewed buying pressure. Lots of profit taking along the day, and closed the day near the top, which is generally considered a bullish sign. Bearish divergence between the top, just 4 days ago, and yesterday, however, so...

Barkworth

Left leg, right leg, up or down. Where is she headed? I'm getting more and more messages from people that feel that ACB might implode soon. Personally, I am not that scared. Last week's move down was caused by SPY pulling back, and the lack of volume made it stay where it was. We need SPY to remain stabile while we wait for ACB to present their next earnings. I...

Barkworth

It would seem that ZYNE got a bit ahead of itself. We were very extended on 26, 29 and 30 April, and finally saw some healthy consolidation with an initial 5% pull back. SPY was making ripples yesterday, and probably added much to panic reaction, more than 20% down. I bought that dip with much gratitude, and relished when buying pressure forced her back up to...

Barkworth

We need to see ZYNE break $12.05 with confidence today. If she does, we'll see the 100EMA cross the 150EMA. In any event, I really don't think we're looking at any deeper pull back at the moment. ZYNE is happening. I have a bullish position right now, so I am just going to hold. If we break upward today, I'm going to add to my position. Roth just added a $36...

Barkworth Updated 

The 50 EMA has been on the way up for a while, and even the 300 EMA is starting to curve upward. The 100EMA is about to cross the 200EMA, and it doesn't look like it is going to stop there. ZYNE has a short term target of about $15, and a longer term target (early next year) of $24-ish. I got in at $3.60. This is a real winner, so far.

Barkworth

Where is she headed? This has to the be THE single most undervalued pot stock at this time. With a capacity that is greater than Cronos, this #6 biggest player by production capacity is long overdue for some attention. Strong fundamentals, presenting earning next week. A beat would have this stock search for a weekly lower high, then hopefully a higher low,...

Barkworth Updated 

ACB has been trading sideways once before. That time, it broke out bullish, and set its all time high. This was late 2017. Like then, investors are full of anticipation at this time. Real bad news will see a bearish break out, but anticipated good news will break out bullish.

Barkworth

No reason for RTI to look for lower regions, but in anticipation of the first generated revenue, no reason to look for higher highs either. At some point, one would expect an announcement of how much Aurora will be paying for the implementation of Radient patented technology in its facilities, and Radient should announce being open for business. There is still a...

Barkworth Updated 

The Stoch RSI shows that we still may have some power for a move up, but volume has been on the decline, even if it is still well above average. In addition, we're looking pretty extended on the daily chart. I closed half my position in anticipation of a potential retrace, before a new leg up. I have studied ZYNE's historical movements, and its behaviour is quite...

Barkworth

Sometimes you just need to zoom out more, to get the broader picture. With CRON trading at 11 times forward revenue at the CURRENT price, it is still extremely expensive. Disappointing results, nothing much to show for all its promise. It seems to me that the only thing it has going for it right now, is Altria's cash. Looking at the weekly charts, it would seem...